(Monday 14 October 2024, Vienna, Austria) Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results